Appendices: Real-world treatment, clinical outcomes and healthcare resource utilization among persons with hemophilia A by age

These are peer-reviewed appendices for the article 'Real-world treatment, clinical outcomes and healthcare resource utilization among persons with hemophilia A by age' published in the Journal of Comparative Effectiveness Research.Appendix A. NDC, GPI, and HCPCS Codes for Hemophilia-related Therapies.Appendix B. ICD-9/10 and CPT Codes for Hemophilia-related Diagnoses and Events.Appendix C. Exclusions.Appendix D. LOINC Codes.Appendix E. ICD-9/10 Procedure and CPT Codes for Joint Procedures and Surgery.Appendix F. Fracture Codes.Summary: Aim: Examine real-world characteristics, treatment patterns, and outcomes among treated persons with hemophilia A (PwHA) stratified by age. Patients & methods: This study utilized US claims data from 1 January 2007–31 July 2018 from the Humana Research Database. Unadjusted comparisons were conducted across PwHA (

本数据集为《比较疗效研究杂志》中发表的《按年龄分层分析患有A型血友病人群的真实世界治疗、临床结局及医疗资源利用》一文的同行评审附录。附录A：血友病相关治疗药物的国家药品代码（NDC）、玻璃体酶抑制剂（GPI）和卫生保健程序代码（HCPCS）。附录B：血友病相关诊断和事件的国际疾病分类第9版/第10版（ICD-9/10）和医疗程序代码（CPT）。附录C：排除项。附录D：实验室和观察指标（LOINC）代码。附录E：关节手术和程序的国际疾病分类第9版/第10版（ICD-9/10）和医疗程序代码（CPT）。附录F：骨折代码。摘要：研究目的：考察按年龄分层治疗A型血友病人群（PwHA）的真实世界特征、治疗模式和结局。研究方法：本研究利用了Humana研究数据库中2007年1月1日至2018年7月31日的美国索赔数据。对治疗A型血友病人群进行了未调整的比较。